Novartis/MIT Partner To Develop Continuous Drug Manufacturing Technologies
This article was originally published in The Pink Sheet Daily
Executive Summary
Novartis and MIT will “own the IP rights together,” Novartis’ Van Laar tells “The Pink Sheet” DAILY.